Cargando…

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19

PURPOSE: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory coronavirus 2 (SARS-CoV-2) has spread around the world. Differentiation between pure viral COVID-19 pneumonia and secondary infection can be challenging. In patients with elevated C-reactive protein (CRP) on admission ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pink, Isabell, Raupach, David, Fuge, Jan, Vonberg, Ralf-Peter, Hoeper, Marius M., Welte, Tobias, Rademacher, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140571/ https://www.ncbi.nlm.nih.gov/pubmed/34021897 http://dx.doi.org/10.1007/s15010-021-01615-8

Ejemplares similares

Clinical and Microbiological Effects of an Antimicrobial Stewardship Program in Urology—A Single Center Before-After Study
por: Joean, Oana, et al.
Publicado: (2022)

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
por: Kamp, Jan C., et al.
Publicado: (2021)

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
por: Rademacher, Jessica, et al.
Publicado: (2023)

Capillary pCO(2) helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
por: Olsson, Karen M, et al.
Publicado: (2015)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2022)

The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza
por: Christensen, Ingrid, et al.
Publicado: (2023)

C-reactive protein and procalcitonin during course of sepsis and septic shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Hospital physicians’ experiences with procalcitonin – implications for antimicrobial stewardship; a qualitative study
por: Christensen, Ingrid, et al.
Publicado: (2020)

Häufigkeit, Spektrum und Risikofaktoren von Long-COVID
por: Pink, Isabell, et al.
Publicado: (2022)

Häufigkeit, Spektrum und Risikofaktoren von Long-COVID
por: Pink, Isabell, et al.
Publicado: (2022)

Risiko und Häufigkeit von Long-COVID
por: Pink, Isabell, et al.
Publicado: (2023)

C-reactive protein-guided use of procalcitonin in COVID-19
por: Houghton, Rebecca, et al.
Publicado: (2021)

Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid Tumors
por: Vassallo, Matteo, et al.
Publicado: (2021)

C-reactive protein and procalcitonin in patients with DRESS syndrome
por: Taegtmeyer, Anne, et al.
Publicado: (2014)

Computed Tomography in Adults with Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: Typical Imaging Findings
por: Dettmer, Sabine, et al.
Publicado: (2021)

Impact of Procalcitonin Levels Combined With Active Intervention on Antimicrobial Stewardship in a Community Hospital
por: Newton, James A, et al.
Publicado: (2019)

Evaluation of procalcitonin-guided antimicrobial stewardship in patients admitted to hospital with COVID-19 pneumonia
por: Calderon, Maria, et al.
Publicado: (2021)

356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2021)

Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin
por: Ming, Damien K., et al.
Publicado: (2021)

Procalcitonin-guided diagnosis and antibiotic stewardship revisited
por: Sager, Ramon, et al.
Publicado: (2017)

Discrepancy of C-Reactive Protein, Procalcitonin and Interleukin-6 at Hospitalization: Infection in Patients with Normal C-Reactive Protein, Procalcitonin and High Interleukin-6 Values
por: Lee, Eun-Hwa, et al.
Publicado: (2022)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Procalcitonin, cytokines and C-reactive protein in systemic inflammatory response
por: Tesinsky, P, et al.
Publicado: (1998)

C-reactive protein and procalcitonin in septic and HIV infection patients
por: Silva, JM, et al.
Publicado: (2009)

Procalcitonin and C-reactive protein in urinary tract infection diagnosis
por: Xu, Rui-Ying, et al.
Publicado: (2014)

Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia
por: Oksuz, Lutfiye, et al.
Publicado: (2015)

Procalcitonin and C-reactive protein in the diagnosis of spontaneous bacterial peritonitis
por: Verma, Rajanshu, et al.
Publicado: (2022)

Low Sensitivity of Procalcitonin for Bacteremia at an Academic Medical Center: A Cautionary Tale for Antimicrobial Stewardship
por: Goodlet, Kellie J, et al.
Publicado: (2020)

859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023)

Correction to: Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin
por: Ming, Damien K., et al.
Publicado: (2021)

Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice
por: Park, Dae Won, et al.
Publicado: (2022)

P36 Procalcitonin as an antimicrobial stewardship tool in the COVID-19 era: a single centre experience
por: Creedon, Margaret, et al.
Publicado: (2022)

Etiology of bacteremias associated with c-reactive protein, procalcitonin and lactate levels
por: de la Torre-Prados, MV, et al.
Publicado: (2015)

Correlation of Redox Status with Procalcitonin and C-reactive Protein in Septic Patients
por: Petrovic, Jasna, et al.
Publicado: (2020)

1334. Performance of C-Reactive Protein and Procalcitonin in Immunocompromised Children with SIRS
por: Posch, Leila C, et al.
Publicado: (2019)

Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma
por: Franceschi, Elisa, et al.
Publicado: (2022)

2004. Impact of Procalcitonin Roll-out Without Antimicrobial Stewardship Guidance in a Community Hospital Emergency Department
por: Mena Lora, Alfredo J, et al.
Publicado: (2019)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
por: Watkins, Andrew B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kkama6s2nduatt8t0ctkucto40